AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

AtriCure Inc. (ATRC)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

39.27

0.26 (0.67%)

At close: Feb 20, 2025, 3:59 PM

39.16

-0.27%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	37.75
Market Cap	1.92B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.95
PE Ratio (ttm)	-41.33
Forward PE	n/a
Analyst	Buy

Ask	41.75
Volume	365,141
Avg. Volume (20D)	500,898
Open	38.85
Previous Close	39.01
Day's Range	37.81 - 39.62
52-Week Range	18.94 - 43.11
Beta	undefined

About ATRC

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Aug 5, 2005

Employees 1,300

Stock Exchange NASDAQ

Ticker Symbol ATRC

Website https://www.atricure.com

Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for ATRC stock is "Buy." The 12-month stock price forecast is $51, which is an increase of 29.89% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

AtriCure Inc. is scheduled to release its earnings on Apr 30, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-6.54%

AtriCure shares are trading lower. The company rep... Unlock content with Pro Subscription

1 month ago

+9.49%

Atricure shares are trading higher after announced a year-over-year increase in preliminary Q4 and FY24 revenue results.

News

1 week ago · zacks.com

AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know

AtriCure (ATRC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 week ago · seekingalpha.com

AtriCure, Inc. (ATRC) Q4 2024 Earnings Call Transcript

AtriCure, Inc. (NASDAQ:ATRC ) Q4 2024 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Office...

1 week ago · zacks.com

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings

While the top- and bottom-line numbers for AtriCure (ATRC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compa...

1 week ago · zacks.com

AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates

AtriCure (ATRC) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.21 per share a year ago.

1 week ago · businesswire.com

AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-op...

1 week ago · zacks.com

Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS

Besides Wall Street's top -and-bottom-line estimates for AtriCure (ATRC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the q...

2 weeks ago · zacks.com

Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know

AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago · businesswire.com

AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results

2 months ago · businesswire.com

AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference